Triglyceride Lowering Study

Status unconfirmed · Phase 4

Conditions studied: Hypertriglyceridemia

In brief

Lovaza is a special fish oil concentrate, that prescribed at 4 g a day to reduce certain fat (triglycerides) levels in blood.Our goal is to study how Lovaza at doses of 4, 8, and 12 grams per day will reduce fats in the blood of the patients with very high level of triglycerides. Our hypothesis is that patients with very high triglycerides will respond more with higher doses of Lovaza (8 g per day and then 12 g per day).

Key facts

Study ID
NCT00934219
Run by
Jewish Hospital, Cincinnati, Ohio
People needed
25
Starts
2009-07-01
Expected to finish
2012-12-01
Last updated by the study team
2009-07-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.